← Back to headlines
BioMarin Earnings Expected Amidst Drug Competition
BioMarin Pharmaceutical's earnings report is anticipated as its key drug faces increasing competition in the market.
6 Aug, 19:32 — 6 Aug, 19:32
Sources
Showing 1 of 1 sources
Related Stories
Meta Agrees to $17 Billion Settlement Over Teen Social Media Addiction Claims
28m ago
Armenian Banking Group Acquires Key Georgian Financial Assets
29m ago
Dubai Set to Award Dh55 Billion in Contracts for Airport Expansion
35m ago
Analysts Preview Second-Quarter Earnings for HealthEquity and Burlington
38m ago